Bromantane is described primarily as a mild psychostimulant[REF] and anxiolytic [REF].
Bromantane has been found to lower the levels of pro-inflammatory cytokines IL-6, IL-17 and IL-4 and to normalize behavior in animal models of depression, and may possess clinical efficacy as an antidepressant [REF].